Growth Metrics

Burning Rock Biotech (BNR) Consolidated Net Income: 2020-2024

Historic Consolidated Net Income for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$45.9 million.

  • Burning Rock Biotech's Consolidated Net Income rose 62.43% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year increase of 78.00%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • As of FY2024, Burning Rock Biotech's Consolidated Net Income stood at -$45.9 million, which was up 49.80% from -$91.4 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Consolidated Net Income ranged from a high of -$45.9 million in FY2024 and a low of -$140.2 million during FY2022.
  • For the 3-year period, Burning Rock Biotech's Consolidated Net Income averaged around -$92.5 million, with its median value being -$91.4 million (2023).
  • Per our database at Business Quant, Burning Rock Biotech's Consolidated Net Income plummeted by 99.86% in 2021 and then soared by 49.80% in 2024.
  • MRY analysis of 5 years shows Burning Rock Biotech's Consolidated Net Income stood at -$62.4 million in 2020, then tumbled by 99.86% to -$124.7 million in 2021, then decreased by 12.43% to -$140.2 million in 2022, then soared by 34.83% to -$91.4 million in 2023, then surged by 49.80% to -$45.9 million in 2024.
  • Its Consolidated Net Income was -$45.9 million in FY2024, compared to -$91.4 million in FY2023 and -$140.2 million in FY2022.